RxDoctor Payments Data

Marcelino Oliveri, DO

Orthopaedic Surgery of the Spine · Lancaster, PANPI 1154317105

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,875 of the $10,448 with a category attached, or 75.4%. Biotronik NRO, Inc. accounts for 83.0% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $8,818, more than ten times the $308 reported in 2019.

$10,448in general payments, 2019–2025

Across 45 payments — averaging $232.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotronik NRO, Inc.$9K
  • Boston Scientific$643
  • Intrinsic Therapeutics$373
  • Medtronic$190
  • Relievant Medsystems, Inc.$143
  • Zimmer Biomet$124
  • plus $298 from 6 others

What the payments were for

  • Consulting fees$7,87575%
  • Travel & lodging$1,04910%
  • Food & beverage$1,52515%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biotronik NRO, Inc.7$8,677
Boston Scientific7$643
Intrinsic Therapeutics7$373
Medtronic(2 entities)9$190
Relievant Medsystems, Inc.2$143
Zimmer Biomet5$124
Vertos Medical, Inc.1$118
Alevio, LLC1$50
Novus Surgical Consultants1$48
Electronic Waveform Lab, Inc.3$42
Si-bone, Inc.1$27
Nevro Corp.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,448 in reported general payments places this provider in the 55th percentile of 43 orthopaedic surgery of the spine providers in Pennsylvania.

See all orthopaedic surgery of the spine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$214,825
Medicare patients
413
Services billed
1,553

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin91$561
Oxycodone Hcl62$336
Prednisone59$235
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$217
Diclofenac Sodium16$183
Cyclobenzaprine Hcl31$109
Tramadol Hcl43$73
Meloxicam64$70

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →